TCP Regimen in Newly Diagnosed MCD:a Prospective, Single-center, Single-arm, Phase-II Pilot Trial

NCT03043105 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

25

Enrollment

OTHER

Sponsor class

Conditions

Multicentric Castleman Disease

Interventions

DRUG: Thalidomide, cyclophosphamide and prednisone

Sponsor

Peking Union Medical College Hospital